Latest OPSSD News
The Food and Drug Administration (FDA) has approved a first-of-its-kind pancreatic cancer drug. It’s a daily pill called Rasonque. This offers a new approach to treating the deadly illness.
Dr. Jeremy Jacox of Yale School of Medicine and Yale Cancer Center offered insight on what makes the drug stand out, how it can pave the way for more cancer treatments, the high cost of the drug, and why pancreatic cancer is so much deadlier than other cancers.
- August 24, 2026Source: Survivornet (With Jeffrey Ishizuka, MD, DPhil)
A new experimental vaccine is showing incredible potential as a treatment option for melanoma, one of the most dangerous types of skin cancer. Compared to other types of skin cancer, melanoma is much more likely to spread to other parts of the body if not found and treated early. Even when it is surgically removed, melanoma can return, or recur.
- August 21, 2026
Joao P. De Aquino, MD, assistant professor of psychiatry, has been awarded an R01 grant to build a human laboratory model of how alcohol affects pain in people living with alcohol use disorder, chronic pain, or both.
- August 20, 2026Source: Everyday Health (With Jeffrey Ishizuka, MD, DPhil)
Adults at high risk of melanoma recurrence and spread were able to stay cancer-free with personalized vaccines made with mRNA technology.
- August 19, 2026Source: WTNH-TV Online (with David Braun MD, PhD)
David Braum, MD, joined WTNH's Health Headlines segment to bring awareness about kidney cancer.
- August 12, 2026
David Braun, MD, PhD, associate professor of internal medicine (medical oncology and hematology), has been selected by the leadership committee of the 2026 Kidney Cancer Research Summit as the recipient of the 2026 KidneyCAN Catalyst Award.
- August 12, 2026
Adati Tarfa, PharmD, PhD, instructor in the Department of Internal Medicine, received a National Institute on Drug Abuse (NIDA) K99/R00 Pathway to Independence Award to support her research on a community pharmacy-based model integrating HIV and substance use disorder care.
- August 12, 2026
The Yale Center for Clinical Investigation (YCCI) has named its 2026 Scholars—early-career researchers who will receive added support as they build their careers. YCCI Scholars include junior faculty, postdoctoral trainees, and predoctoral trainees.
- July 17, 2026
Women’s Health Research at Yale announced the five latest pilot projects to join its program, and a partnership with Yale Cancer Center.
- July 15, 2026
Siyuan Cheng, PhD, and Yaru Xu, PhD, associate research scientists in the Ping Mu Lab, were recently awarded the Urology Care Foundation Research Scholar Award, established to recruit outstanding young investigators into urologic research and foster their career success.